Pathelen® Hybrid Vet
UniPharma Pathelen Vets Presentation 2020 (8.3).pdf
DOPING TEST SAFE!
Pathelen® Hybrid Vet for the use on all animal open wounds contains a unique patented formula, which when shaken for 15-20 seconds, will grow visibly in density by more then 20 times, creating the advanced sorption property and filling the bottle content.
Pathelen® Hybrid Vet is a Class I medical device (CE), specifically designed and developed for the treatment of multi-resistant bacteria (such as MRSA) in open wounds. Vitally, bacteria are unable to develop resistance to it, in contrast to all antibiotics designed to perform a similar function.
Pathelen® eliminates most external bacterial wound infections within 5-10 days in most cases such as preparing for a wound closure surgery or enhancing the growth of granulating tissue on the treated wound.
It has a wide range of antimicrobial uses, highly effective in combating gram-positive and gram-negative aerobic and anaerobic micro-organisms (clostridial and non-clostridial in composition with aerobic and facultative anaerobic).
Ingredients | % FDA-CODE CAS No Function | |
Aerosil 300Pharma | 64% A2C 7631-86-9 Active Substance | |
Aerosil R972 Pharma | 35.9% 68 611-44-9 Active Substance | |
Benzalkonium Chloride | 0.1% 63449-41-2 Surfactant |
Why is Pathelen® Hybrid Vet so Effective?
Rapidly removes toxins from any wound and heals it
Bacteria can’t develop resistance
Blocks corrosive properties of saliva and lymph
Very high sorption and does not penetrate the blood circle
Removes bacteria and prevents it from re-entering the wound
Efficiently eliminates the multi-resistant bacteria flora
Destroys micro-organism optimal living conditions
Inhibits surface and intracavitary bleeding
Reduces risk of sepsis and considerably reduces infection
Decreases exotoxins production
Can be used with other medicines and has no known side effects
Easy to store and use requires minimal training
